NSG
PACB icon

Nalls Sherbakoff Group’s Pacific Biosciences PACB Stock Holding History

Nalls Sherbakoff Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$30 Hold
16
– – ﹤0.01% 441
2025
Q3 		$20 Hold
16
– – ﹤0.01% 425
2025
Q2 		$20 Sell
16
-18
-53% -$21 ﹤0.01% 428
2025
Q1 		$40 Buy
+34
New +$52 ﹤0.01% 434
2023
Q4 		$334 Hold
34
– – ﹤0.01% 432
2023
Q3 		$284 Hold
34
– – ﹤0.01% 445
2023
Q2 		$421 Hold
34
– – ﹤0.01% 459
2023
Q1 		$332 Buy
+34
New +$338 ﹤0.01% 493

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return